MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate in the 1-on-1 meetings at ...

NEW YORK--(BUSINESS WIRE)--Soterix Medical, Inc. announced today the receipt of CE Mark approval for its 1x1 tDCS ™ Therapy System for the treatment of Major Depressive Disorder (MDD).